Vanberra Signal

Erasa Skincare

Curated by Signal

Line of skincare products

Overview

Erasa Skincare products are developed and marketed by BioMimetic Laboratories, a line of skincare products. The company's first product Erasa XEP-30 is a biomimetic concentrated synthetic neuropeptide that helps in relaxing the surface of the skin to help erase the appearance of wrinkles, including deep frown and expression lines, as well as helps to correct and repair loss of elasticity and dullness. It sells its products through authorized retailers and distributors in the United States and Puerto Rico, as well as online. The company was incorporated in 2014 and is based in Orangeburg, New York. Incubated by Skyler Brand Ventures with Valmiki Capital Management as the lead investor.

Key facts

Founded
2014

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Retail Technology companies
  • Internet-first brand offering self care and beauty products for pregnant and nursing moms

    Retail TechnologyLos Angeles, United States
  • Provider AI-based autonomous store solutions for retailers and brands

    Retail TechnologySanta Clara, United States

About Erasa Skincare

What does Erasa Skincare do?

Erasa Skincare products are developed and marketed by BioMimetic Laboratories, a line of skincare products.

Where is Erasa Skincare headquartered?

Erasa Skincare is headquartered in New York City, United States.

When was Erasa Skincare founded?

Erasa Skincare was founded in 2014.

Which sector is Erasa Skincare in?

Erasa Skincare operates in Retail Technology.

Who are Erasa Skincare's competitors?

Companies similar to Erasa Skincare include Beauxi, Dr. Harter’s Botanicals, and AiFi.